Novel formulations of alpha2,4-disulfophenyl-n-tert-butylnitrone

Details for Australian Patent Application No. 2001260935 (hide)

Owner AstraZeneca AB

Inventors Eriksson, Patrik; Andersson, Mattias; Andersson, Mats J.

Agent Freehills

Pub. Number AU-B-2001260935

PCT Pub. Number WO01/89507

Priority 0001916 23.05.00 SE

Filing date 22 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 19 May 2005

International Classifications

A61K 031/15 - Oximes (CNO)

A61K 009/08 Medicinal preparations characterised by special physical form - Solutions

Event Publications

19 May 2005 Application Accepted

  Published as AU-B-2001260935

15 September 2005 Standard Patent Sealed

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001260936-New process

2001260934